News

  Zenicor Medical Systems AB (publ) has been selected as sole supplier for a screening programme in the UK for atrial fibrillation. The screening programme […]

”Thumbs up for Zenicor – a healthy growth story” Read the analysis here

Read more about the study here: ACE-1950 study Aftenposten article  (Only in Norwegian)

Zenicor Medical Systems announces that the pilot project that has been carried out in northern Finland during the first half of 2017 has shown positive […]

Zenicor-ECG is once again the chosen system for screening in a NHS England setting. This time an elderly population will be screened with the Zenicor […]

This October, a project screening for atrial fibrillation will commence at the University Hospital in Friborg (HFR Fribourg), Switzerland. The project is the first screening […]

In a recently completed project at Queen Alexandra hospital in Portsmouth twice as many stroke patients received the correct Atrial Fibrillation diagnosis with Zenicor-ECG compared to current standard of care. The aim of the project was to develop and improve the diagnosis of Atrial Fibrillation for stroke patients in Portsmouth and to prevent recurrent strokes. The study was presented at the European Stroke Organisation Conference in Venice.

Zenicor now listed by BNK Service as one of eight selected purchasing partners.

In April the first patients were included in the STROKESTOP 2 study. The aim of the study is to prevent stroke by screening for silent Atrial Fibrillation with Zenicor thumb-ECG and to initiate stroke preventive treatment. The study will include all 75 and 76 year old citizens in Stockholm.

A new large study, STROKESTOP II, will be conducted during 2016 and 2017.